echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Coatings News > Paints and Coatings Market > China Nuclear Titanium Dioxide: plans to increase capital of 780 million yuan in Oriental Titanium

    China Nuclear Titanium Dioxide: plans to increase capital of 780 million yuan in Oriental Titanium

    • Last Update: 2021-04-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    CNNC Titanium Dioxide (002145) announced on the evening of March 23 that, in order to expand the business of Gansu Oriental Titanium Co.
    , Ltd.
    , a wholly-owned subsidiary of CNNC Huayuan Titanium Dioxide Co.
    , Ltd.
    , the company plans to invest in cash to its wholly-owned subsidiary Gansu Oriental Titanium.
    Industry Co.
    , Ltd.
    increased its capital by RMB 780 million.
    After the capital increase is completed, the registered capital of Oriental Titanium will increase from RMB 800 million to RMB 1.
    58 billion, and the company directly holds 100% of its equity.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.